La voix de M. René Viviani, Président du Conseil des ministres : discours prononcé le 22 décembre 1914

[Discours. 1914-12-22]

22/12/19, réouverture du musée du Rhin à la maison de Victor Hugo, [6] place des Vosges [à Paris] : [photographie de presse] / [Agence Rol]

Référence bibliographique : Rol, 57302

Lottery Action, August 9-22, 2004, Vol. 11, no. 15

Iowa Lottery Authority Retailer Information Newsletter

Histoire du dix-neuvième siècle depuis les traités de Vienne. Tome 22 / G. G. Gervinus,... ; traduit de l'allemand par J.-F. Minssen,...

Collection : Collection d'historiens contemporains

La maladie de Wilson: un caméléon clinique auquel il faut penser [A primer on Wilson disease for the general practitioner].

Wilson disease (WD) is an inherited disorder of hepatic copper excretion leading to toxic accumulation of copper in the liver as well as the brain, cornea, and other organs. The defect is due to mutations of the copper-transporting ATPase ATP7B. Clinical manifestations are highly variable and comprise acute liver failure, chronic hepatitis and cirrhosis as well as neurological or psychiatric symptoms. The Kayser-Fleischer corneal ring is pathognomonic but absent in about 50% of patients with hepatic manifestations alone. A high index of suspicion in clinically compatible situations is key, with a combination of laboratory tests allowing the diagnosis of WD. Treatment is based on the use of chelating agents, D-penicillamine or trientine. Liver transplantation should be considered for patients with acute liver failure or advanced cirrhosis.

De nouvelles méthodes pour relier le déclenchement des symptômes respiratoires à l'exposition aux moisissures

Un nombre de plus en plus important d'études proposent l'exposition aux moisissures de l'environnement intérieur comme un facteur majeur dans l'apparition de symptômes respiratoires chez l'adulte et dans le développement de l'asthme chez l'enfant. Afin de contrôler l'incidence de telles pathologies dans la population générale, il est indispensable premièrement, de déterminer le niveau d'exposition aux particules fongiques qui déclenche les symptômes et deuxièmement d'identifier un marqueur environnemental associé de manière significative au tableau clinique. La première étude, choisie dans le cadre de cette note, s'inscrit dans le premier volet. Elle explore la relation entre la colonisation par des moisissures des voies aériennes de personnes asthmatiques et la concentration en spores de ces espèces fongiques dans l'air des habitations. La deuxième étude répond à la deuxième problématique en montrant qu'un marqueur environnemental, la fraction de (1-3)-beta-D-glucanes présente à la surface des particules fongiques, est corrélée au tableau des symptômes cliniques.

ABD e-News October 22, 2004

Weekly newsletter for the State of Iowa Alcoholic Beverages Division

T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion protein.

ABSTRACT: BACKGROUND: EMD 521873 (Selectikine or NHS-IL2LT) is a fusion protein consisting of modified human IL-2 which binds specifically to the high-affinity IL-2 receptor, and an antibody specific for both single- and double-stranded DNA, designed to facilitate the enrichment of IL-2 in tumor tissue. METHODS: An extensive analysis of pharmacodynamic (PD) markers associated with target modulation was assessed during a first-in-human phase I dose-escalation trial of Selectikine. RESULTS: Thirty-nine patients with metastatic or locally advanced tumors refractory to standard treatments were treated with increasing doses of Selectikine, and nine further patients received additional cyclophosphamide. PD analysis, assessed during the first two treatment cycles, revealed strong activation of both CD4+ and CD8+ T-cells and only weak NK cell activation. No dose response was observed. As expected, Treg cells responded actively to Selectikine but remained at lower frequency than effector CD4+ T-cells. Interestingly, patient survival correlated positively with both high lymphocyte counts and low levels of activated CD8+ T-cells at baseline, the latter of which was associated with enhanced T-cell responses to the treatment. CONCLUSIONS: The results confirm the selectivity of Selectikine with predominant T-cell and low NK cell activation, supporting follow-up studies assessing the clinical efficacy of Selectikine for cancer patients.

Quand faut-il opérer une fracture isolée du tiers moyen de la clavicule [When to operate an isolated midshaft clavicle fracture?]

Slightly displaced clavicular midshaft fracture is currently treated nonoperatively. There is considerable debate about whether acute displaced fractures should be treated operatively. Nonunion rate after displaced fracture has been underestimated for a long time, and malunion clinical impact often minimized. It is known that operative treatment decreases these rates. However, operating all displaced fractures may lead to overtreatment. Acute operative treatment of midshaft fractures with delayed treatment of established nonunion showed no significant difference in the outcome, but malunion surgical management is technically demanding. Consequently these fractures could be treated surgically, but operative indication should be adapted to patient expectations.

Lottery Action, November 21 - December 12, 2004, Vol. 11, no 22

Lottery Newsletter for Lottery Retailers